Clinical trial
Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW)
NCT06177574 is registered in ClinicalTrials.gov with Carmen Hidalgo Tenorio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Bictegravir/Emtricitavine/Tenofovir Alafenamide in HIV-1 Infected naïve Patients Using Test and Treat Stategy Rapid-initiation Model of Care: BIC-NOW Clinical Trial (BIC-NOW)
- Lead sponsor
- Carmen Hidalgo Tenorio
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 27, 2020
- Completion date
- October 30, 2023
- Enrollment
- 208 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.